TR199701148T1 - Virüslerin ve kanserlerin gelismesini önlemeye mahsus, N-fosfonoglisin türevlerini içeren bir farmasötik bilesim. - Google Patents
Virüslerin ve kanserlerin gelismesini önlemeye mahsus, N-fosfonoglisin türevlerini içeren bir farmasötik bilesim.Info
- Publication number
- TR199701148T1 TR199701148T1 TR97/01148T TR9701148T TR199701148T1 TR 199701148 T1 TR199701148 T1 TR 199701148T1 TR 97/01148 T TR97/01148 T TR 97/01148T TR 9701148 T TR9701148 T TR 9701148T TR 199701148 T1 TR199701148 T1 TR 199701148T1
- Authority
- TR
- Turkey
- Prior art keywords
- cancers
- pharmaceutical composition
- viruses
- inhibiting
- development
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Bu bulus, memlilerde özellikle insan ve sicak kanli hayvanlarda kanserler ve tümörlerin büyümesini engelleyen bir farmasötik bilesimdir.Bilesim ayni zamanda virüslere karsida etkilidir. bileim, sistemik herbisitler oaln N-fosfonoglisin türevlerini ihtiva etmektedir. Bilesim, ayni zamanda , kanserler ve tumörlerin iyilestirilmesi için kemoterapik maddeler ile bir arada N-fosfonoglisin türevlerinidi ihtiva etmektedir. Istege bagli potansiyotörler de katilabilecektir. Bir potansiyatör ile N-fosfonoglisin türevleri viral enfeksiyonlarin tedavi edilmesi için kullanilabilecektir.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/420,940 US5665713A (en) | 1995-04-12 | 1995-04-12 | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
US184095P | 1995-08-03 | 1995-08-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199701148T1 true TR199701148T1 (tr) | 1998-02-21 |
Family
ID=26669550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR97/01148T TR199701148T1 (tr) | 1995-04-12 | 1996-04-11 | Virüslerin ve kanserlerin gelismesini önlemeye mahsus, N-fosfonoglisin türevlerini içeren bir farmasötik bilesim. |
Country Status (18)
Country | Link |
---|---|
US (3) | US5665713A (tr) |
EP (1) | EP0820291A1 (tr) |
JP (1) | JPH11503458A (tr) |
KR (1) | KR19980703830A (tr) |
CN (1) | CN1181014A (tr) |
AR (1) | AR003120A1 (tr) |
AU (1) | AU714057B2 (tr) |
BR (1) | BR9604951A (tr) |
CA (1) | CA2217951A1 (tr) |
CZ (1) | CZ323897A3 (tr) |
IL (1) | IL117873A (tr) |
NO (1) | NO974694L (tr) |
NZ (1) | NZ305783A (tr) |
PL (1) | PL322734A1 (tr) |
SK (1) | SK138297A3 (tr) |
TR (1) | TR199701148T1 (tr) |
TW (1) | TW457088B (tr) |
WO (1) | WO1996032115A1 (tr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA962879B (en) * | 1995-04-12 | 1997-03-17 | Procter & Gamble | A pharmaceutical composition for inhibiting the growth of viruses and cancers |
US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
US6262093B1 (en) | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
US5665713A (en) * | 1995-04-12 | 1997-09-09 | Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
US6265427B1 (en) | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
US6686391B2 (en) | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
DE19622355A1 (de) * | 1996-06-04 | 1997-12-11 | Bayer Ag | Formkörper die agrochemische Mittel freisetzen |
US5900429A (en) | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
PE11499A1 (es) * | 1997-05-16 | 1999-03-01 | Procter & Gamble | Tratamiento del hiv y cancer |
AU747407B2 (en) * | 1998-04-14 | 2002-05-16 | Bioagency Ag | Use of organophosphoric compounds for the therapeutic and preventative treatment of infections |
US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
US6407105B1 (en) | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6608096B1 (en) * | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6462062B1 (en) | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
US7060643B2 (en) * | 2000-12-28 | 2006-06-13 | Showa Denko Kabushiki Kaisha | Photo-functional powder and applications thereof |
US6515074B2 (en) * | 2001-01-22 | 2003-02-04 | Delphi Technologies, Inc. | Thermoplastic polymer alloy compositions and process for manufacture thereof |
US20040006043A1 (en) * | 2002-07-02 | 2004-01-08 | Ramot University Authority For Applied Research & Industrial Development Ltd. | Methods, pharmaceutical compositions and pharmaceutical kits for enhancing the therapeutic efficiency of cancer chemotherapeutic agents |
US7151092B2 (en) * | 2002-10-31 | 2006-12-19 | Metabasis Therapeutics, Inc. | Cytarabine monophosphate prodrugs |
EP2034828A4 (en) * | 2006-05-19 | 2011-04-06 | Univ Illinois | PHOSPHOROUS COMPOUNDS CONTAINING TRIPHENYLMETHYLPHOSPHONATE ESTERS FOR THE TREATMENT OF MELANOMA AND OTHER CANCERS |
WO2014025765A2 (en) * | 2012-08-06 | 2014-02-13 | University Of Miami | Systems and methods for adaptive neural decoding |
AU2015217221A1 (en) | 2014-02-13 | 2016-08-11 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
EP3164136A4 (en) | 2014-07-02 | 2018-04-04 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and uses therof |
AU2019207625A1 (en) | 2018-01-09 | 2020-07-30 | Ligand Pharmaceuticals, Inc. | Acetal compounds and therapeutic uses thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3779758A (en) * | 1969-03-25 | 1973-12-18 | Photocircuits Corp | Photosensitive process for producing printed circuits employing electroless deposition |
US3853530A (en) * | 1971-03-10 | 1974-12-10 | Monsanto Co | Regulating plants with n-phosphonomethylglycine and derivatives thereof |
US3799758A (en) * | 1971-08-09 | 1974-03-26 | Monsanto Co | N-phosphonomethyl-glycine phytotoxicant compositions |
US3903297A (en) * | 1973-11-01 | 1975-09-02 | Upjohn Co | Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs |
US4408052A (en) * | 1980-02-27 | 1983-10-04 | Takeda Chemical Industries, Ltd. | Phospholipid carbamates |
JPS5772914A (en) * | 1980-10-22 | 1982-05-07 | Takeda Chem Ind Ltd | Antitumor agent |
EP0061872B1 (en) * | 1981-03-30 | 1985-08-07 | Takeda Chemical Industries, Ltd. | Ethyleneglycol derivatives, their production and use |
US4634693A (en) * | 1983-07-28 | 1987-01-06 | Cardarelli Nathan F | Tin steroids and their uses |
JPS6081194A (ja) * | 1983-10-11 | 1985-05-09 | Takeda Chem Ind Ltd | ケトアルキルリン脂質 |
JPS6081193A (ja) * | 1983-10-11 | 1985-05-09 | Takeda Chem Ind Ltd | リン脂質 |
DE3804686A1 (de) * | 1988-02-15 | 1989-08-24 | Henkel Kgaa | Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten |
US4866059A (en) * | 1988-04-04 | 1989-09-12 | Warner-Lambert Company | '(2S)-(5-amino-1,2-dihydro-2-methyl-3-phenylpyrido(3,4-b)pyrazin-7-yl)-carbamic acid, ethyl ester |
US5114951A (en) * | 1989-04-11 | 1992-05-19 | Burroughs Wellcome Company | Agents for combating multiple drug resistance |
US4994591A (en) * | 1989-06-02 | 1991-02-19 | The Research Foundation Of State University Of Ny | Platinum complexes derived from b-silyamines |
US5665713A (en) * | 1995-04-12 | 1997-09-09 | Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
-
1995
- 1995-04-12 US US08/420,940 patent/US5665713A/en not_active Expired - Fee Related
-
1996
- 1996-04-11 CZ CZ973238A patent/CZ323897A3/cs unknown
- 1996-04-11 KR KR1019970707230A patent/KR19980703830A/ko not_active Application Discontinuation
- 1996-04-11 AU AU53896/96A patent/AU714057B2/en not_active Ceased
- 1996-04-11 TR TR97/01148T patent/TR199701148T1/tr unknown
- 1996-04-11 CA CA002217951A patent/CA2217951A1/en not_active Abandoned
- 1996-04-11 CN CN96193250A patent/CN1181014A/zh active Pending
- 1996-04-11 PL PL96322734A patent/PL322734A1/xx unknown
- 1996-04-11 IL IL11787396A patent/IL117873A/en not_active IP Right Cessation
- 1996-04-11 EP EP96910802A patent/EP0820291A1/en not_active Withdrawn
- 1996-04-11 NZ NZ305783A patent/NZ305783A/en unknown
- 1996-04-11 SK SK1382-97A patent/SK138297A3/sk unknown
- 1996-04-11 BR BR9604951A patent/BR9604951A/pt not_active Application Discontinuation
- 1996-04-11 WO PCT/US1996/004954 patent/WO1996032115A1/en not_active Application Discontinuation
- 1996-04-11 JP JP8531151A patent/JPH11503458A/ja active Pending
- 1996-04-12 AR ARP960102170A patent/AR003120A1/es not_active Application Discontinuation
- 1996-05-13 TW TW085105605A patent/TW457088B/zh active
- 1996-07-15 US US08/680,469 patent/US5854231A/en not_active Expired - Fee Related
-
1997
- 1997-10-10 NO NO974694A patent/NO974694L/no not_active Application Discontinuation
-
1998
- 1998-12-24 US US09/220,914 patent/US6090796A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL117873A0 (en) | 1996-08-04 |
NO974694L (no) | 1997-12-12 |
NZ305783A (en) | 2001-06-29 |
CN1181014A (zh) | 1998-05-06 |
BR9604951A (pt) | 1998-06-09 |
KR19980703830A (ko) | 1998-12-05 |
CZ323897A3 (cs) | 1998-03-18 |
SK138297A3 (en) | 1998-05-06 |
WO1996032115A1 (en) | 1996-10-17 |
TW457088B (en) | 2001-10-01 |
AU5389696A (en) | 1996-10-30 |
PL322734A1 (en) | 1998-02-16 |
CA2217951A1 (en) | 1996-10-17 |
US5665713A (en) | 1997-09-09 |
US6090796A (en) | 2000-07-18 |
JPH11503458A (ja) | 1999-03-26 |
AR003120A1 (es) | 1998-07-08 |
IL117873A (en) | 2001-05-20 |
NO974694D0 (no) | 1997-10-10 |
EP0820291A1 (en) | 1998-01-28 |
AU714057B2 (en) | 1999-12-16 |
US5854231A (en) | 1998-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199701148T1 (tr) | Virüslerin ve kanserlerin gelismesini önlemeye mahsus, N-fosfonoglisin türevlerini içeren bir farmasötik bilesim. | |
TR199701147T1 (tr) | Kanserlerin gelismesini önlemeye mahsus, benzimidazol içeren bir farmasötik bilesim. | |
TR199701150T1 (tr) | Memeli canlilarda virüslerin ve kanserlerin gelismesini önlemeye mahsus, N-klorofenil karbamatlari, N-klorofeniltiokarbamatlari ve N-fosfonoglisin türevlerini içeren bir farmasötik bilesim. | |
TR199801216T2 (tr) | Virüslerin gelismesini önlemeye mahsus, N-klorofenil karbamatlari ve N-klorofeniltiokarbamatlari içeren bir farmasötik bilesim. | |
TR200002243T2 (tr) | Arsenik trioksitin hazırlanması için işlem ve bunların kanser tedavisi için kullanımı. | |
NL300216I1 (nl) | Pyranonverbindingen die bruikbaar zijn voor het behandelen van retroviarale infecties. | |
PT696326E (pt) | Utilizacao de ndv no fabrico de um medicamento para tratamento do cancro | |
TR200100859T2 (tr) | Asetildinalin ve gemsitabin, kapesitabin veya cisplatin kombinasyonu ile kanser kemoterapisi | |
YU7296A (sh) | Farmaceutska kompozicija koja sadrži kombinaciju jedne protivvirusne supstance i jednog protivzapaljenskog glukokortikoida | |
ES2191292T3 (es) | Compuestos antivirales poliaromaticos. | |
TR199800244T2 (tr) | Griseofulvinin, kanserlerin ilerlemesini önlemede kullanimi. | |
TR199701534T1 (tr) | 1,2,4-triazol türevlerinin, kanserlerin tedavisi için bir ilaç üretilmesinde kullanimi. | |
AR002987A1 (es) | Composicion farmaceutica para el tratamiento de infecciones virales ocanceres o tumores, composicion de dosis unitaria que la comprende y uso para dicho tratamiento | |
JPS5735516A (en) | Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation | |
MX9800944A (es) | Uso de derivados de 1h-1,2,4-triazol para inhibir el crecimiento de canceres. | |
DK474688A (da) | Praeparat til bekaempelse af tumor eller kraeftceller | |
ATE338553T1 (de) | Antitumorkombination aus 3-amino-1,2,4- benzotriazine 1,4-dioxid/paclitaxel/platin | |
TR199902730T2 (tr) | Glikrizikasit ve antiviral etkinlik kazandirilmis en azindan bir proteini içeren farmasötik antiviral bilesim. | |
ATE236651T1 (de) | Materialen und verfahren im zusammenhang mit der inhibierung der wechselwirkung der p53 und mdm2 | |
DK0980205T3 (da) | Anvendelse af en kombination af TALL-104 celler med adriamycin eller cisplatin i behandlingen af maligniteter | |
TR199800302A2 (tr) | Bunaklikta kullanima yönelik kombinasyon preparati. | |
MX9707808A (es) | Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres. | |
ATE417926T1 (de) | Zusammensetzungen zur modulierung der länge von telomeren | |
MX9707810A (es) | Una composicion farmaceutica que contiene derivados de n-fosfonoglicina para inhibir el crecimiento de virus y canceres. | |
BR9811147A (pt) | Método de tratamento de câncer em hospedeiros mamìferos e processos de preparação de derivados de 13-deoxiantraciclina |